Segment disclosures

Company overview

BRUKER CORPORATION

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

41 dimension combinations 642 retained observations 67 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Intersegment Elimination · BSIBMID

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBMIDMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD20261105Open filing evidence
2026-01-01 – 2026-09-300 USD20261105Open filing evidence
2025-07-01 – 2025-09-300 USD20261105Open filing evidence
2025-01-01 – 2025-09-300 USD20261105Open filing evidence

Intersegment Elimination · Bsi Calid

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiCalidMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-03-310 USD20260507Open filing evidence
2025-01-01 – 2025-12-310 USD20260227Open filing evidence
2025-07-01 – 2025-09-300 USD20251105Open filing evidence
2025-01-01 – 2025-09-300 USD20251105Open filing evidence
2025-04-01 – 2025-06-300 USD20260805Open filing evidence
2025-01-01 – 2025-06-300 USD20260805Open filing evidence
2025-01-01 – 2025-03-310 USD20260507Open filing evidence
2024-01-01 – 2024-12-310 USD20260227Open filing evidence
2024-07-01 – 2024-09-300 USD20251105Open filing evidence
2024-01-01 – 2024-09-300 USD20251105Open filing evidence
2024-04-01 – 2024-06-300 USD20250806Open filing evidence
2024-01-01 – 2024-06-300 USD20250806Open filing evidence
2024-01-01 – 2024-03-310 USD20250507Open filing evidence
2023-01-01 – 2023-12-310 USD20260227Open filing evidence
2022-01-01 – 2022-12-310 USD20250303Open filing evidence

Intersegment Elimination · Energy And Supercon Technologies

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-302000000 USD20261105Open filing evidence
2026-01-01 – 2026-09-308200000 USD20261105Open filing evidence
2026-04-01 – 2026-06-303000000 USD20260805Open filing evidence
2026-01-01 – 2026-06-306200000 USD20260805Open filing evidence
2026-01-01 – 2026-03-313200000 USD20260507Open filing evidence
2025-01-01 – 2025-12-317700000 USD20260227Open filing evidence
2025-07-01 – 2025-09-301200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-305700000 USD20261105Open filing evidence
2025-04-01 – 2025-06-302100000 USD20260805Open filing evidence
2025-01-01 – 2025-06-304500000 USD20260805Open filing evidence
2025-01-01 – 2025-03-312400000 USD20260507Open filing evidence
2024-01-01 – 2024-12-3114100000 USD20260227Open filing evidence
2024-07-01 – 2024-09-303800000 USD20251105Open filing evidence
2024-01-01 – 2024-09-3010300000 USD20251105Open filing evidence
2024-04-01 – 2024-06-304000000 USD20250806Open filing evidence
2024-01-01 – 2024-06-306500000 USD20250806Open filing evidence
2024-01-01 – 2024-03-312500000 USD20250507Open filing evidence
2023-01-01 – 2023-12-3117000000 USD20260227Open filing evidence
2022-01-01 – 2022-12-3112300000 USD20250303Open filing evidence

Operating Segments · Bruker Bio Spin Group

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerBioSpinGroupMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-30233000000 USD20241107Open filing evidence
2024-01-01 – 2024-09-30633300000 USD20241107Open filing evidence
2024-04-01 – 2024-06-30217500000 USD20240809Open filing evidence
2024-01-01 – 2024-06-30400300000 USD20240809Open filing evidence
2023-07-01 – 2023-09-30198300000 USD20241107Open filing evidence
2023-01-01 – 2023-09-30540600000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30162000000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30342300000 USD20240809Open filing evidence
2023-01-01 – 2023-03-31180300000 USD20230510Open filing evidence
2022-07-01 – 2022-09-30175700000 USD20231109Open filing evidence
2022-01-01 – 2022-09-30493300000 USD20231109Open filing evidence
2022-04-01 – 2022-06-30159800000 USD20230809Open filing evidence
2022-01-01 – 2022-06-30317600000 USD20230809Open filing evidence
2022-01-01 – 2022-03-31157800000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31691000000 USD20220228Open filing evidence
2021-07-01 – 2021-09-30186500000 USD20221104Open filing evidence
2021-01-01 – 2021-09-30494400000 USD20221104Open filing evidence
2021-04-01 – 2021-06-30148500000 USD20220805Open filing evidence
2021-01-01 – 2021-06-30307900000 USD20220805Open filing evidence
2021-01-01 – 2021-03-31159400000 USD20220506Open filing evidence
2020-01-01 – 2020-12-31600000000 USD20210301Open filing evidence
2019-01-01 – 2019-12-31621400000 USD20210301Open filing evidence
2018-01-01 – 2018-12-31591100000 USD20210301Open filing evidence

Operating Segments · Bruker Calid Group

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerCalidGroupMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31227900000 USD20240510Open filing evidence
2023-07-01 – 2023-09-30239300000 USD20231109Open filing evidence
2023-01-01 – 2023-09-30703200000 USD20231109Open filing evidence
2023-04-01 – 2023-06-30227200000 USD20230809Open filing evidence
2023-01-01 – 2023-06-30463900000 USD20230809Open filing evidence
2023-01-01 – 2023-03-31236700000 USD20240510Open filing evidence
2022-07-01 – 2022-09-30207500000 USD20231109Open filing evidence
2022-01-01 – 2022-09-30601000000 USD20231109Open filing evidence
2022-04-01 – 2022-06-30190300000 USD20230809Open filing evidence
2022-01-01 – 2022-06-30393500000 USD20230809Open filing evidence
2022-01-01 – 2022-03-31203200000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31819600000 USD20220228Open filing evidence
2021-07-01 – 2021-09-30194200000 USD20221104Open filing evidence
2021-01-01 – 2021-09-30579900000 USD20221104Open filing evidence
2021-04-01 – 2021-06-30193300000 USD20220805Open filing evidence
2021-01-01 – 2021-06-30385700000 USD20220805Open filing evidence
2021-01-01 – 2021-03-31192400000 USD20220506Open filing evidence
2020-01-01 – 2020-12-31653900000 USD20210301Open filing evidence
2019-01-01 – 2019-12-31623500000 USD20220228Open filing evidence
2018-01-01 – 2018-12-31547800000 USD20210301Open filing evidence

Operating Segments · Bruker Nano Group

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerNanoGroupMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-30287100000 USD20241107Open filing evidence
2024-01-01 – 2024-09-30780000000 USD20241107Open filing evidence
2024-04-01 – 2024-06-30252500000 USD20240809Open filing evidence
2024-01-01 – 2024-06-30492900000 USD20240809Open filing evidence
2024-01-01 – 2024-03-31240400000 USD20240510Open filing evidence
2023-07-01 – 2023-09-30238700000 USD20241107Open filing evidence
2023-01-01 – 2023-09-30673400000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30225100000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30434700000 USD20240809Open filing evidence
2023-01-01 – 2023-03-31209600000 USD20240510Open filing evidence
2022-07-01 – 2022-09-30199100000 USD20231109Open filing evidence
2022-01-01 – 2022-09-30559800000 USD20231109Open filing evidence
2022-04-01 – 2022-06-30182200000 USD20230809Open filing evidence
2022-01-01 – 2022-06-30360700000 USD20230809Open filing evidence
2022-01-01 – 2022-03-31178500000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31697500000 USD20220228Open filing evidence
2021-07-01 – 2021-09-30174900000 USD20221104Open filing evidence
2021-01-01 – 2021-09-30504600000 USD20221104Open filing evidence
2021-04-01 – 2021-06-30175300000 USD20220805Open filing evidence
2021-01-01 – 2021-06-30329700000 USD20220805Open filing evidence
2021-01-01 – 2021-03-31154400000 USD20220506Open filing evidence
2020-01-01 – 2020-12-31556100000 USD20220228Open filing evidence
2019-01-01 – 2019-12-31632700000 USD20210301Open filing evidence
2018-01-01 – 2018-12-31568100000 USD20210301Open filing evidence

Operating Segments · Bsi Biospin

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31798500000 USD20240229Open filing evidence
2023-01-01 – 2023-03-31180300000 USD20230510Open filing evidence
2022-01-01 – 2022-12-31696700000 USD20240229Open filing evidence
2022-01-01 – 2022-03-31157800000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31691000000 USD20240229Open filing evidence
2020-01-01 – 2020-12-31600000000 USD20230301Open filing evidence

Operating Segments · BSIBMID

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBMIDMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30133600000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30395800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30130200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30373300000 USD20261105Open filing evidence

Operating Segments · Bsi Calid

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiCalidMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30310300000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30626600000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31316300000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311210200000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30312700000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30878600000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30285800000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30565900000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31280100000 USD20260507Open filing evidence
2024-01-01 – 2024-12-311093500000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30279400000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30772900000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30265600000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30493500000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31227900000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31960400000 USD20260227Open filing evidence
2023-01-01 – 2023-03-31236700000 USD20230510Open filing evidence
2022-01-01 – 2022-12-31822200000 USD20250303Open filing evidence
2022-01-01 – 2022-03-31203200000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31819600000 USD20240229Open filing evidence
2020-01-01 – 2020-12-31653900000 USD20230301Open filing evidence

Operating Segments · Bsi Nano

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31941900000 USD20240229Open filing evidence
2023-01-01 – 2023-03-31209600000 USD20230510Open filing evidence
2022-01-01 – 2022-12-31787000000 USD20240229Open filing evidence
2022-07-01 – 2022-09-30199100000 USD20221104Open filing evidence
2022-01-01 – 2022-09-30559800000 USD20221104Open filing evidence
2022-04-01 – 2022-06-30182200000 USD20220805Open filing evidence
2022-01-01 – 2022-06-30360700000 USD20220805Open filing evidence
2022-01-01 – 2022-03-31178500000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31697500000 USD20240229Open filing evidence
2021-07-01 – 2021-09-30174900000 USD20221104Open filing evidence
2021-01-01 – 2021-09-30504600000 USD20221104Open filing evidence
2021-04-01 – 2021-06-30175300000 USD20220805Open filing evidence
2021-01-01 – 2021-06-30329700000 USD20220805Open filing evidence
2021-01-01 – 2021-03-31154400000 USD20220506Open filing evidence
2020-01-01 – 2020-12-31556100000 USD20230301Open filing evidence
2020-07-01 – 2020-09-30147100000 USD20201106Open filing evidence
2020-01-01 – 2020-09-30392700000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30125500000 USD20200807Open filing evidence
2020-01-01 – 2020-06-30245600000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31120100000 USD20200511Open filing evidence
2019-01-01 – 2019-12-31632700000 USD20220228Open filing evidence
2019-07-01 – 2019-09-30169900000 USD20201106Open filing evidence
2019-01-01 – 2019-09-30461700000 USD20201106Open filing evidence
2019-04-01 – 2019-06-30151000000 USD20200807Open filing evidence
2019-01-01 – 2019-06-30291800000 USD20200807Open filing evidence
2019-01-01 – 2019-03-31140800000 USD20200511Open filing evidence
2018-01-01 – 2018-12-31568100000 USD20210301Open filing evidence

Operating Segments · Energy And Supercon Technologies

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3082100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30223100000 USD20261105Open filing evidence
2026-04-01 – 2026-06-3074200000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30141000000 USD20260805Open filing evidence
2026-01-01 – 2026-03-3166800000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31270900000 USD20260227Open filing evidence
2025-07-01 – 2025-09-3073800000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30199400000 USD20261105Open filing evidence
2025-04-01 – 2025-06-3066300000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30125600000 USD20260805Open filing evidence
2025-01-01 – 2025-03-3159300000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31283000000 USD20260227Open filing evidence
2024-07-01 – 2024-09-3068700000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30210900000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3069100000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30142200000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3173100000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31280700000 USD20260227Open filing evidence
2023-07-01 – 2023-09-3070600000 USD20241107Open filing evidence
2023-01-01 – 2023-09-30205500000 USD20241107Open filing evidence
2023-04-01 – 2023-06-3072700000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30134900000 USD20240809Open filing evidence
2023-01-01 – 2023-03-3162200000 USD20240510Open filing evidence
2022-01-01 – 2022-12-31237100000 USD20250303Open filing evidence
2022-07-01 – 2022-09-3059300000 USD20231109Open filing evidence
2022-01-01 – 2022-09-30178200000 USD20231109Open filing evidence
2022-04-01 – 2022-06-3059200000 USD20230809Open filing evidence
2022-01-01 – 2022-06-30118900000 USD20230809Open filing evidence
2022-01-01 – 2022-03-3159700000 USD20230510Open filing evidence
2021-01-01 – 2021-12-31223800000 USD20240229Open filing evidence
2021-07-01 – 2021-09-3057000000 USD20221104Open filing evidence
2021-01-01 – 2021-09-30166000000 USD20221104Open filing evidence
2021-04-01 – 2021-06-3056600000 USD20220805Open filing evidence
2021-01-01 – 2021-06-30109000000 USD20220805Open filing evidence
2021-01-01 – 2021-03-3152400000 USD20220506Open filing evidence
2020-01-01 – 2020-12-31189500000 USD20230301Open filing evidence
2020-07-01 – 2020-09-3043800000 USD20201106Open filing evidence
2020-01-01 – 2020-09-30134800000 USD20211105Open filing evidence
2020-04-01 – 2020-06-3044800000 USD20200807Open filing evidence
2020-01-01 – 2020-06-3091000000 USD20210805Open filing evidence
2020-01-01 – 2020-03-3146200000 USD20200511Open filing evidence
2019-01-01 – 2019-12-31209900000 USD20210301Open filing evidence
2019-07-01 – 2019-09-3052500000 USD20201106Open filing evidence
2019-01-01 – 2019-09-30152200000 USD20201106Open filing evidence
2019-04-01 – 2019-06-3051900000 USD20200807Open filing evidence
2019-01-01 – 2019-06-3099700000 USD20200807Open filing evidence
2019-01-01 – 2019-03-3147800000 USD20200511Open filing evidence
2018-01-01 – 2018-12-31194800000 USD20210301Open filing evidence
2018-07-01 – 2018-09-3050900000 USD2019-11-04 · 21:18:05.000ZOpen filing evidence
2018-01-01 – 2018-09-30139200000 USD2019-11-04 · 21:18:05.000ZOpen filing evidence
2018-04-01 – 2018-06-3042700000 USD2019-08-09 · 19:26:23.000ZOpen filing evidence
2018-01-01 – 2018-06-3088300000 USD2019-08-09 · 19:26:23.000ZOpen filing evidence
2018-01-01 – 2018-03-3145600000 USD20190508Open filing evidence
2017-01-01 – 2017-12-31191200000 USD20200327Open filing evidence

Operating Segments · Scientific Instruments

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30383200000 USD20221104Open filing evidence
2022-01-01 – 2022-09-301094300000 USD20221104Open filing evidence
2022-04-01 – 2022-06-30350100000 USD20220805Open filing evidence
2022-01-01 – 2022-06-30711100000 USD20220805Open filing evidence
2022-01-01 – 2022-03-31361000000 USD20220506Open filing evidence
2021-01-01 – 2021-12-311510600000 USD20220228Open filing evidence
2021-07-01 – 2021-09-30380700000 USD20221104Open filing evidence
2021-01-01 – 2021-09-301074300000 USD20221104Open filing evidence
2021-04-01 – 2021-06-30341800000 USD20220805Open filing evidence
2021-01-01 – 2021-06-30693600000 USD20220805Open filing evidence
2021-01-01 – 2021-03-31351800000 USD20220506Open filing evidence
2020-01-01 – 2020-12-311253900000 USD20220228Open filing evidence
2020-07-01 – 2020-09-30323400000 USD20201106Open filing evidence
2020-01-01 – 2020-09-30842600000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30257800000 USD20200807Open filing evidence
2020-01-01 – 2020-06-30519200000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31261400000 USD20200511Open filing evidence
2019-01-01 – 2019-12-311244900000 USD20220228Open filing evidence
2019-07-01 – 2019-09-30301900000 RestatedUSD20201106Open filing evidence
2019-01-01 – 2019-09-30869300000 RestatedUSD20201106Open filing evidence
2019-04-01 – 2019-06-30291400000 RestatedUSD20200807Open filing evidence
2019-01-01 – 2019-06-30567400000 RestatedUSD20200807Open filing evidence
2019-01-01 – 2019-03-31276000000 RestatedUSD20200511Open filing evidence
2018-01-01 – 2018-12-311138900000 USD20210301Open filing evidence
2018-07-01 – 2018-09-30417100000 USD2019-11-04 · 21:18:05.000ZOpen filing evidence
2018-01-01 – 2018-09-301206500000 USD2019-11-04 · 21:18:05.000ZOpen filing evidence
2018-04-01 – 2018-06-30402400000 USD2019-08-09 · 19:26:23.000ZOpen filing evidence
2018-01-01 – 2018-06-30789400000 USD2019-08-09 · 19:26:23.000ZOpen filing evidence
2018-01-01 – 2018-03-31387000000 USD20190508Open filing evidence
2017-01-01 – 2017-12-311070900000 USD20200327Open filing evidence

Operating Segments · Energy And Supercon Technologies

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-31194800000 USD20190301Open filing evidence
2018-07-01 – 2018-09-3050900000 USD20181109Open filing evidence
2018-01-01 – 2018-09-30139200000 USD20181109Open filing evidence
2018-04-01 – 2018-06-3042700000 USD20180809Open filing evidence
2018-01-01 – 2018-06-3088300000 USD20180809Open filing evidence
2018-01-01 – 2018-03-3145600000 USD20180510Open filing evidence
2017-01-01 – 2017-12-31191200000 USD20190301Open filing evidence
2017-07-01 – 2017-09-3046100000 USD20181109Open filing evidence
2017-01-01 – 2017-09-30140200000 USD20181109Open filing evidence
2017-04-01 – 2017-06-3054000000 USD20180809Open filing evidence
2017-01-01 – 2017-06-3094100000 USD20180809Open filing evidence
2017-01-01 – 2017-03-3140100000 USD20180510Open filing evidence
2016-01-01 – 2016-12-31130200000 USD20190301Open filing evidence
2016-07-01 – 2016-09-3035500000 USD20171109Open filing evidence
2016-01-01 – 2016-09-3091200000 USD20171109Open filing evidence
2016-04-01 – 2016-06-3028500000 USD20170809Open filing evidence
2016-01-01 – 2016-06-3055700000 USD20170809Open filing evidence
2016-01-01 – 2016-03-3127200000 USD20170510Open filing evidence
2015-01-01 – 2015-12-31133700000 USD20180316Open filing evidence
2015-07-01 – 2015-09-3032900000 USD20161109Open filing evidence
2015-01-01 – 2015-09-3091200000 USD20161109Open filing evidence
2015-04-01 – 2015-06-3030800000 USD20160805Open filing evidence
2015-01-01 – 2015-06-3058300000 USD20160805Open filing evidence
2015-01-01 – 2015-03-3127500000 USD20160506Open filing evidence
2014-01-01 – 2014-12-31152900000 USD20170301Open filing evidence
2014-07-01 – 2014-09-3040000000 USD20151106Open filing evidence
2014-01-01 – 2014-09-30116200000 USD20151106Open filing evidence
2014-04-01 – 2014-06-3041400000 USD20150807Open filing evidence
2014-01-01 – 2014-06-3076200000 USD20150807Open filing evidence
2014-01-01 – 2014-03-3134800000 USD20150508Open filing evidence
2013-01-01 – 2013-12-31147400000 USD20160229Open filing evidence
2013-07-01 – 2013-09-3032500000 USD20141107Open filing evidence
2013-01-01 – 2013-09-30100800000 USD20141107Open filing evidence
2012-01-01 – 2012-12-31136200000 USD20150227Open filing evidence

Operating Segments · Scientific Instruments

Consolidation Items · Statement Business Segments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember
PeriodValueUnitFiledEvidence
2018-01-01 – 2018-12-311707000000 USD20190301Open filing evidence
2018-07-01 – 2018-09-30417100000 USD20181109Open filing evidence
2018-01-01 – 2018-09-301206500000 USD20181109Open filing evidence
2018-04-01 – 2018-06-30402400000 USD20180809Open filing evidence
2018-01-01 – 2018-06-30789400000 USD20180809Open filing evidence
2018-01-01 – 2018-03-31387000000 USD20180510Open filing evidence
2017-01-01 – 2017-12-311583900000 USD20190301Open filing evidence
2017-07-01 – 2017-09-30390600000 USD20181109Open filing evidence
2017-01-01 – 2017-09-301099500000 USD20181109Open filing evidence
2017-04-01 – 2017-06-30362500000 USD20180809Open filing evidence
2017-01-01 – 2017-06-30708900000 USD20180809Open filing evidence
2017-01-01 – 2017-03-31346400000 USD20180510Open filing evidence
2016-01-01 – 2016-12-311492600000 USD20190301Open filing evidence
2016-07-01 – 2016-09-30361500000 USD20171109Open filing evidence
2016-01-01 – 2016-09-301057600000 USD20171109Open filing evidence
2016-04-01 – 2016-06-30345700000 USD20170809Open filing evidence
2016-01-01 – 2016-06-30696100000 USD20170809Open filing evidence
2016-01-01 – 2016-03-31350400000 USD20170510Open filing evidence
2015-01-01 – 2015-12-311499200000 USD20180316Open filing evidence
2015-07-01 – 2015-09-30366600000 USD20161109Open filing evidence
2015-01-01 – 2015-09-301060300000 USD20161109Open filing evidence
2015-04-01 – 2015-06-30366200000 USD20160805Open filing evidence
2015-01-01 – 2015-06-30693700000 USD20160805Open filing evidence
2015-01-01 – 2015-03-31327500000 USD20160506Open filing evidence
2014-01-01 – 2014-12-311674600000 USD20170301Open filing evidence
2014-07-01 – 2014-09-30383400000 USD20151106Open filing evidence
2014-01-01 – 2014-09-301198800000 USD20151106Open filing evidence
2014-04-01 – 2014-06-30421500000 USD20150807Open filing evidence
2014-01-01 – 2014-06-30815400000 USD20150807Open filing evidence
2014-01-01 – 2014-03-31393900000 USD20150508Open filing evidence
2013-01-01 – 2013-12-311709500000 USD20160229Open filing evidence
2013-07-01 – 2013-09-30410600000 USD20141107Open filing evidence
2013-01-01 – 2013-09-301198500000 USD20141107Open filing evidence
2012-01-01 – 2012-12-311666100000 USD20150227Open filing evidence

Operating Segments · Scientific Instruments · Bruker Bio Spin Group

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:SubsegmentsAxis=brkr:BrukerBioSpinGroupMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-30139500000 USD20181109Open filing evidence
2018-01-01 – 2018-09-30411200000 USD20181109Open filing evidence
2018-04-01 – 2018-06-30139900000 USD20180809Open filing evidence
2018-01-01 – 2018-06-30271700000 USD20180809Open filing evidence
2018-01-01 – 2018-03-31131800000 USD20180510Open filing evidence

Operating Segments · Scientific Instruments · Bruker Calid Group

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:SubsegmentsAxis=brkr:BrukerCalidGroupMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-30134600000 USD20181109Open filing evidence
2018-01-01 – 2018-09-30393900000 USD20181109Open filing evidence
2018-04-01 – 2018-06-30128000000 USD20180809Open filing evidence
2018-01-01 – 2018-06-30259300000 USD20180809Open filing evidence
2018-01-01 – 2018-03-31131300000 USD20180510Open filing evidence

Operating Segments · Scientific Instruments · Bruker Nano Group

Consolidation Items · Statement Business Segments · Subsegments

Source dimensions us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:SubsegmentsAxis=brkr:BrukerNanoGroupMember
PeriodValueUnitFiledEvidence
2018-07-01 – 2018-09-30143000000 USD20181109Open filing evidence
2018-01-01 – 2018-09-30401400000 USD20181109Open filing evidence
2018-04-01 – 2018-06-30134500000 USD20180809Open filing evidence
2018-01-01 – 2018-06-30258400000 USD20180809Open filing evidence
2018-01-01 – 2018-03-31123900000 USD20180510Open filing evidence

Bruker Bio Spin Group

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerBioSpinGroupMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30186500000 USD20211105Open filing evidence
2021-01-01 – 2021-09-30494400000 USD20211105Open filing evidence
2021-04-01 – 2021-06-30148500000 USD20210805Open filing evidence
2021-01-01 – 2021-06-30307900000 USD20210805Open filing evidence
2021-01-01 – 2021-03-31159400000 USD20210510Open filing evidence
2020-07-01 – 2020-09-30152100000 USD20211105Open filing evidence
2020-01-01 – 2020-09-30398100000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30125100000 USD20210805Open filing evidence
2020-01-01 – 2020-06-30246000000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31120900000 USD20210510Open filing evidence

Bruker Bio Spin Group · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerBioSpinGroupMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31182800000 USD20240510Open filing evidence
2023-01-01 – 2023-03-31180300000 USD20240510Open filing evidence
2020-01-01 – 2020-12-31600000000 USD20220228Open filing evidence
2019-01-01 – 2019-12-31621400000 USD20220228Open filing evidence

Bruker Calid Group

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerCalidGroupMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30194200000 USD20211105Open filing evidence
2021-01-01 – 2021-09-30579900000 USD20211105Open filing evidence
2021-04-01 – 2021-06-30193300000 USD20210805Open filing evidence
2021-01-01 – 2021-06-30385700000 USD20210805Open filing evidence
2021-01-01 – 2021-03-31192400000 USD20210510Open filing evidence
2020-07-01 – 2020-09-30171300000 USD20211105Open filing evidence
2020-01-01 – 2020-09-30444500000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30132700000 USD20210805Open filing evidence
2020-01-01 – 2020-06-30273200000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31140500000 USD20210510Open filing evidence

Bruker Calid Group · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerCalidGroupMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2024-07-01 – 2024-09-30279400000 USD20241107Open filing evidence
2024-01-01 – 2024-09-30772900000 USD20241107Open filing evidence
2024-04-01 – 2024-06-30265600000 USD20240809Open filing evidence
2024-01-01 – 2024-06-30493500000 USD20240809Open filing evidence
2023-07-01 – 2023-09-30239300000 USD20241107Open filing evidence
2023-01-01 – 2023-09-30703200000 USD20241107Open filing evidence
2023-04-01 – 2023-06-30227200000 USD20240809Open filing evidence
2023-01-01 – 2023-06-30463900000 USD20240809Open filing evidence
2020-01-01 – 2020-12-31653900000 USD20220228Open filing evidence

Bruker Nano Group

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerNanoGroupMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30174900000 USD20211105Open filing evidence
2021-01-01 – 2021-09-30504600000 USD20211105Open filing evidence
2021-04-01 – 2021-06-30175300000 USD20210805Open filing evidence
2021-01-01 – 2021-06-30329700000 USD20210805Open filing evidence
2021-01-01 – 2021-03-31154400000 USD20210510Open filing evidence
2020-07-01 – 2020-09-30147100000 USD20211105Open filing evidence
2020-01-01 – 2020-09-30392700000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30125500000 USD20210805Open filing evidence
2020-01-01 – 2020-06-30245600000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31120100000 USD20210510Open filing evidence

Bruker Nano Group · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BrukerNanoGroupMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-31632700000 USD20220228Open filing evidence

BSIBIOS

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBIOSMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30397200000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301154800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30391200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301117100000 USD20261105Open filing evidence

BSIBIOS · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBIOSMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD20261105Open filing evidence
2026-01-01 – 2026-09-300 USD20261105Open filing evidence
2025-07-01 – 2025-09-300 USD20261105Open filing evidence
2025-01-01 – 2025-09-300 USD20261105Open filing evidence

BSIBIOS · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBIOSMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30397200000 USD20261105Open filing evidence
2026-01-01 – 2026-09-301154800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30391200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-301117100000 USD20261105Open filing evidence

Bsi Biospin

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30195700000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30393200000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31197500000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31878800000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30208700000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30611800000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30195300000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30403100000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31207800000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31905700000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30233000000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30633300000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30217500000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30400300000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31182800000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31798500000 USD20260227Open filing evidence
2022-01-01 – 2022-12-31696700000 USD20250303Open filing evidence

Bsi Biospin · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-03-310 USD20260507Open filing evidence
2025-01-01 – 2025-12-310 USD20260227Open filing evidence
2025-07-01 – 2025-09-300 USD20251105Open filing evidence
2025-01-01 – 2025-09-300 USD20251105Open filing evidence
2025-04-01 – 2025-06-300 USD20260805Open filing evidence
2025-01-01 – 2025-06-300 USD20260805Open filing evidence
2025-01-01 – 2025-03-310 USD20260507Open filing evidence
2024-01-01 – 2024-12-310 USD20260227Open filing evidence
2024-07-01 – 2024-09-300 USD20251105Open filing evidence
2024-01-01 – 2024-09-300 USD20251105Open filing evidence
2024-04-01 – 2024-06-300 USD20250806Open filing evidence
2024-01-01 – 2024-06-300 USD20250806Open filing evidence
2024-01-01 – 2024-03-310 USD20250507Open filing evidence
2023-01-01 – 2023-12-310 USD20260227Open filing evidence
2022-01-01 – 2022-12-310 USD20250303Open filing evidence

Bsi Biospin · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiBiospinMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30195700000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30393200000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31197500000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31878800000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30208700000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30611800000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30195300000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30403100000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31207800000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31905700000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30233000000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30633300000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30217500000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30400300000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31182800000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31798500000 USD20260227Open filing evidence
2022-01-01 – 2022-12-31696700000 USD20250303Open filing evidence

BSIBMID

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BSIBMIDMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30133600000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30395800000 USD20261105Open filing evidence
2025-07-01 – 2025-09-30130200000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30373300000 USD20261105Open filing evidence

Bsi Calid

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiCalidMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30310300000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30626600000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31316300000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311210200000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30312700000 USD20251105Open filing evidence
2025-01-01 – 2025-09-30878600000 USD20251105Open filing evidence
2025-04-01 – 2025-06-30285800000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30565900000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31280100000 USD20260507Open filing evidence
2024-01-01 – 2024-12-311093500000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30279400000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30772900000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30265600000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30493500000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31227900000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31960400000 USD20260227Open filing evidence
2022-01-01 – 2022-12-31822200000 USD20250303Open filing evidence

Bsi Nano

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30263100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30770400000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30261300000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30507300000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31246000000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311084300000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30266500000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30775200000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30252100000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30508700000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31256600000 USD20260507Open filing evidence
2024-01-01 – 2024-12-311098300000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30287100000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30780000000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30252500000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30492900000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31240400000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31941900000 USD20260227Open filing evidence
2022-01-01 – 2022-12-31787000000 USD20250303Open filing evidence

Bsi Nano · Intersegment Elimination

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD20261105Open filing evidence
2026-01-01 – 2026-09-300 USD20261105Open filing evidence
2026-04-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-06-300 USD20260805Open filing evidence
2026-01-01 – 2026-03-310 USD20260507Open filing evidence
2025-01-01 – 2025-12-310 USD20260227Open filing evidence
2025-07-01 – 2025-09-300 USD20261105Open filing evidence
2025-01-01 – 2025-09-300 USD20261105Open filing evidence
2025-04-01 – 2025-06-300 USD20260805Open filing evidence
2025-01-01 – 2025-06-300 USD20260805Open filing evidence
2025-01-01 – 2025-03-310 USD20260507Open filing evidence
2024-01-01 – 2024-12-310 USD20260227Open filing evidence
2024-07-01 – 2024-09-300 USD20251105Open filing evidence
2024-01-01 – 2024-09-300 USD20251105Open filing evidence
2024-04-01 – 2024-06-300 USD20250806Open filing evidence
2024-01-01 – 2024-06-300 USD20250806Open filing evidence
2024-01-01 – 2024-03-310 USD20250507Open filing evidence
2023-01-01 – 2023-12-310 USD20260227Open filing evidence
2022-01-01 – 2022-12-310 USD20250303Open filing evidence

Bsi Nano · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:BsiNanoMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30263100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30770400000 USD20261105Open filing evidence
2026-04-01 – 2026-06-30261300000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30507300000 USD20260805Open filing evidence
2026-01-01 – 2026-03-31246000000 USD20260507Open filing evidence
2025-01-01 – 2025-12-311084300000 USD20260227Open filing evidence
2025-07-01 – 2025-09-30266500000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30775200000 USD20261105Open filing evidence
2025-04-01 – 2025-06-30252100000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30508700000 USD20260805Open filing evidence
2025-01-01 – 2025-03-31256600000 USD20260507Open filing evidence
2024-01-01 – 2024-12-311098300000 USD20260227Open filing evidence
2024-07-01 – 2024-09-30287100000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30780000000 USD20251105Open filing evidence
2024-04-01 – 2024-06-30252500000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30492900000 USD20250806Open filing evidence
2024-01-01 – 2024-03-31240400000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31941900000 USD20260227Open filing evidence
2022-01-01 – 2022-12-31787000000 USD20250303Open filing evidence
2021-07-01 – 2021-09-30174900000 USD20211105Open filing evidence
2021-04-01 – 2021-06-30175300000 USD20210805Open filing evidence
2021-01-01 – 2021-03-31154400000 USD20210510Open filing evidence
2020-07-01 – 2020-09-30147100000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30125500000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31120100000 USD20210510Open filing evidence

Energy And Supercon Technologies

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3080100000 USD20261105Open filing evidence
2026-01-01 – 2026-09-30214900000 USD20261105Open filing evidence
2026-04-01 – 2026-06-3071200000 USD20260805Open filing evidence
2026-01-01 – 2026-06-30134800000 USD20260805Open filing evidence
2026-01-01 – 2026-03-3163600000 USD20260507Open filing evidence
2025-01-01 – 2025-12-31263200000 USD20260227Open filing evidence
2025-07-01 – 2025-09-3072600000 USD20261105Open filing evidence
2025-01-01 – 2025-09-30193700000 USD20261105Open filing evidence
2025-04-01 – 2025-06-3064200000 USD20260805Open filing evidence
2025-01-01 – 2025-06-30121100000 USD20260805Open filing evidence
2025-01-01 – 2025-03-3156900000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31268900000 USD20260227Open filing evidence
2024-07-01 – 2024-09-3064900000 USD20251105Open filing evidence
2024-01-01 – 2024-09-30200600000 USD20251105Open filing evidence
2024-04-01 – 2024-06-3065100000 USD20250806Open filing evidence
2024-01-01 – 2024-06-30135700000 USD20250806Open filing evidence
2024-01-01 – 2024-03-3170600000 USD20250507Open filing evidence
2023-01-01 – 2023-12-31263700000 USD20260227Open filing evidence
2022-01-01 – 2022-12-31224800000 USD20250303Open filing evidence
2021-07-01 – 2021-09-3057000000 USD20211105Open filing evidence
2021-01-01 – 2021-09-30166000000 USD20211105Open filing evidence
2021-04-01 – 2021-06-3056600000 USD20210805Open filing evidence
2021-01-01 – 2021-06-30109000000 USD20210805Open filing evidence
2021-01-01 – 2021-03-3152400000 USD20210510Open filing evidence
2020-07-01 – 2020-09-3043800000 USD20211105Open filing evidence
2020-01-01 – 2020-09-30134800000 USD20211105Open filing evidence
2020-04-01 – 2020-06-3044800000 USD20210805Open filing evidence
2020-01-01 – 2020-06-3091000000 USD20210805Open filing evidence
2020-01-01 – 2020-03-3146200000 USD20210510Open filing evidence
2019-01-01 – 2019-12-31209900000 USD20200327Open filing evidence
2019-07-01 – 2019-09-3052500000 USD20201106Open filing evidence
2019-01-01 – 2019-09-30152200000 USD20201106Open filing evidence
2019-04-01 – 2019-06-3051900000 USD20200807Open filing evidence
2019-01-01 – 2019-06-3099700000 USD20200807Open filing evidence
2019-01-01 – 2019-03-3147800000 USD20200511Open filing evidence
2018-01-01 – 2018-12-31194800000 USD20200327Open filing evidence
2018-07-01 – 2018-09-3050900000 USD2019-11-04 · 21:18:05.000ZOpen filing evidence
2018-01-01 – 2018-09-30139200000 USD2019-11-04 · 21:18:05.000ZOpen filing evidence
2018-04-01 – 2018-06-3042700000 USD2019-08-09 · 19:26:23.000ZOpen filing evidence
2018-01-01 – 2018-06-3088300000 USD2019-08-09 · 19:26:23.000ZOpen filing evidence
2018-01-01 – 2018-03-3145600000 USD20190508Open filing evidence
2013-01-01 – 2013-12-31147400000 USD20140227Open filing evidence
2013-07-01 – 2013-09-3032500000 USD20131108Open filing evidence
2013-01-01 – 2013-09-30100800000 USD20131108Open filing evidence
2013-04-01 – 2013-06-3037100000 USD20130808Open filing evidence
2013-01-01 – 2013-06-3068300000 USD20130808Open filing evidence
2013-01-01 – 2013-03-3131200000 USD20130509Open filing evidence
2012-01-01 – 2012-12-31136200000 USD20140227Open filing evidence
2012-07-01 – 2012-09-3042400000 USD20131108Open filing evidence
2012-01-01 – 2012-09-3098400000 USD20131108Open filing evidence
2012-04-01 – 2012-06-3026000000 USD20130808Open filing evidence
2012-01-01 – 2012-06-3056000000 USD20130808Open filing evidence
2012-01-01 – 2012-03-3130000000 USD20130509Open filing evidence
2011-01-01 – 2011-12-31113400000 USD20140227Open filing evidence
2011-07-01 – 2011-09-3027700000 USD20121108Open filing evidence
2011-01-01 – 2011-09-3079800000 USD20121108Open filing evidence
2011-04-01 – 2011-06-3028100000 USD20120809Open filing evidence
2011-01-01 – 2011-06-3052100000 USD20120809Open filing evidence
2011-01-01 – 2011-03-3124000000 USD20120509Open filing evidence
2010-01-01 – 2010-12-3190500000 USD20130228Open filing evidence
2010-07-01 – 2010-09-3022400000 USD20111109Open filing evidence
2010-01-01 – 2010-09-3061200000 USD20111109Open filing evidence
2010-04-01 – 2010-06-3018100000 USD20110809Open filing evidence
2010-01-01 – 2010-06-3038800000 USD20110809Open filing evidence
2009-01-01 – 2009-12-3159800000 USD20120229Open filing evidence

Energy And Supercon Technologies · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31223800000 USD20220228Open filing evidence
2021-07-01 – 2021-09-3057000000 USD20211105Open filing evidence
2021-04-01 – 2021-06-3056600000 USD20210805Open filing evidence
2021-01-01 – 2021-03-3152400000 USD20210510Open filing evidence
2020-01-01 – 2020-12-31189500000 USD20220228Open filing evidence
2020-07-01 – 2020-09-3043800000 USD20211105Open filing evidence
2020-04-01 – 2020-06-3044800000 USD20210805Open filing evidence
2020-01-01 – 2020-03-3146200000 USD20210510Open filing evidence
2019-01-01 – 2019-12-31209900000 USD20220228Open filing evidence

Energy And Supercon Technologies · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:EnergyAndSuperconTechnologiesMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2014-04-01 – 2014-06-3041400000 USD20140808Open filing evidence
2014-01-01 – 2014-06-3076200000 USD20140808Open filing evidence
2014-01-01 – 2014-03-3134800000 USD20140509Open filing evidence
2013-04-01 – 2013-06-3037100000 USD20140808Open filing evidence
2013-01-01 – 2013-06-3068300000 USD20140808Open filing evidence
2013-01-01 – 2013-03-3131200000 USD20140509Open filing evidence

Scientific Instruments Material Science

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMaterialScienceMember
PeriodValueUnitFiledEvidence
2019-01-01 – 2019-12-31632700000 USD20200327Open filing evidence
2018-01-01 – 2018-12-31568100000 USD20200327Open filing evidence
2017-01-01 – 2017-12-31513000000 USD20200327Open filing evidence

Scientific Instruments

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember
PeriodValueUnitFiledEvidence
2013-01-01 – 2013-12-311709500000 USD20140227Open filing evidence
2013-07-01 – 2013-09-30410600000 USD20131108Open filing evidence
2013-01-01 – 2013-09-301198500000 USD20131108Open filing evidence
2013-04-01 – 2013-06-30421600000 USD20130808Open filing evidence
2013-01-01 – 2013-06-30787900000 USD20130808Open filing evidence
2013-01-01 – 2013-03-31366300000 USD20130509Open filing evidence
2012-01-01 – 2012-12-311666100000 USD20140227Open filing evidence
2012-07-01 – 2012-09-30408900000 USD20131108Open filing evidence
2012-01-01 – 2012-09-301184000000 USD20131108Open filing evidence
2012-04-01 – 2012-06-30397000000 USD20130808Open filing evidence
2012-01-01 – 2012-06-30775100000 USD20130808Open filing evidence
2012-01-01 – 2012-03-31378100000 USD20130509Open filing evidence
2011-01-01 – 2011-12-311554100000 USD20140227Open filing evidence
2011-07-01 – 2011-09-30394600000 USD20121108Open filing evidence
2011-01-01 – 2011-09-301108300000 USD20121108Open filing evidence
2011-04-01 – 2011-06-30377900000 USD20120809Open filing evidence
2011-01-01 – 2011-06-30713700000 USD20120809Open filing evidence
2011-01-01 – 2011-03-31335800000 USD20120509Open filing evidence
2010-01-01 – 2010-12-311225100000 USD20130228Open filing evidence
2010-07-01 – 2010-09-30290500000 USD20111109Open filing evidence
2010-01-01 – 2010-09-30835700000 USD20111109Open filing evidence
2010-04-01 – 2010-06-30284900000 USD20110809Open filing evidence
2010-01-01 – 2010-06-30545200000 USD20110809Open filing evidence
2009-01-01 – 2009-12-311062700000 USD20120229Open filing evidence

Scientific Instruments · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2021-07-01 – 2021-09-30380700000 USD20211105Open filing evidence
2021-04-01 – 2021-06-30341800000 USD20210805Open filing evidence
2021-01-01 – 2021-03-31351800000 USD20210510Open filing evidence
2020-07-01 – 2020-09-30323400000 USD20211105Open filing evidence
2020-04-01 – 2020-06-30257800000 USD20210805Open filing evidence
2020-01-01 – 2020-03-31261400000 USD20210510Open filing evidence

Scientific Instruments · Operating Segments

Statement Business Segments · Consolidation Items

Source dimensions us-gaap:StatementBusinessSegmentsAxis=brkr:ScientificInstrumentsMember;us-gaap:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember
PeriodValueUnitFiledEvidence
2014-04-01 – 2014-06-30421500000 USD20140808Open filing evidence
2014-01-01 – 2014-06-30815400000 USD20140808Open filing evidence
2014-01-01 – 2014-03-31393900000 USD20140509Open filing evidence
2013-04-01 – 2013-06-30421600000 USD20140808Open filing evidence
2013-01-01 – 2013-06-30787900000 USD20140808Open filing evidence
2013-01-01 – 2013-03-31366300000 USD20140509Open filing evidence